Wang Lei, Cai Hongwei, Wang Yanjin, Liu Jian, Chen Tiange, Liu Jing, Huang Jiapeng, Guo Qulian, Zou Wangyuan
Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
J Clin Anesth. 2022 Feb;76:110575. doi: 10.1016/j.jclinane.2021.110575. Epub 2021 Nov 2.
Enhanced recovery after surgery (ERAS) protocols have been proven to improve outcomes but have not been widely used in neurosurgery. The purpose of this study was to design a multidisciplinary enhanced recovery after elective craniotomy protocol and to evaluate its clinical efficacy and safety after implementation.
A prospective randomized controlled trial.
The setting is at an operating room, a post-anesthesia care unit, and a hospital ward.
This randomized controlled trial (RCT) prospectively analyzed 151 patients who underwent elective craniotomy between January 2019 and June 2020.
The neurosurgical ERAS group was cared for with evidence-based systematic optimization approaches, while the control group received routine care.
The primary outcomes were the postoperative length of stay (LOS) and hospitalization costs. The secondary outcomes included 30-day readmission rates, postoperative complications, postoperative pain scores, length of intensive care unit (ICU) stay, duration of the drainage tube, time to oral intake, time to ambulation, and postoperative functional recovery status.
After ERAS protocol implementation, the median postoperative LOS (4 days to 3 days, difference [95% confidence interval, CI], 2 [1 to 2], P < 0.0001) and hospitalization costs (6266 USD to 5880 USD, difference [95% CI], 427.0 [234.8 to 633.6], P < 0.0001) decreased. Compared to routine perioperative care, the ERAS protocol reduced the incidence of postoperative nausea and vomiting (PONV) (28.0% to 9.2%, adjusted odds ratio [OR] 0.3, 95% CI 0.1-0.7, P = 0.003), shortened urinary catheter removal time by 24 h (64.0% to 83.0%, adjusted OR 2.9, 95% CI 1.3-6.5, P = 0.031), improved ambulation on postoperative day 1 (POD 1) (30.7% to 75.0%, adjusted OR 7.5, 95% CI 3.6-15.8, P < 0.0001), shortened the time to oral intake (15 h to 13 h, difference [95% CI], 3 [1 to 4], P < 0.001), and improved perioperative pain management.
Implementation of an enhanced recovery after elective craniotomy protocol had significant benefits over conventional perioperative management. It was associated with a significant reduction in postoperative length of stay, medical cost, and postoperative complications.
手术加速康复(ERAS)方案已被证明可改善治疗效果,但在神经外科手术中尚未得到广泛应用。本研究的目的是设计一项多学科的择期开颅术后加速康复方案,并评估其实施后的临床疗效和安全性。
一项前瞻性随机对照试验。
手术室、麻醉后监护病房和医院病房。
这项随机对照试验(RCT)前瞻性分析了2019年1月至2020年6月期间接受择期开颅手术的151例患者。
神经外科ERAS组采用循证系统优化方法进行护理,而对照组接受常规护理。
主要结局指标为术后住院时间(LOS)和住院费用。次要结局指标包括30天再入院率、术后并发症、术后疼痛评分、重症监护病房(ICU)住院时间、引流管留置时间、开始经口进食时间、开始行走时间以及术后功能恢复状况。
实施ERAS方案后,术后中位住院时间(从4天降至3天,差值[95%置信区间,CI],2[1至2],P<0.0001)和住院费用(从6266美元降至5880美元,差值[95%CI],427.0[234.8至633.6],P<0.0001)均有所降低。与围手术期常规护理相比,ERAS方案降低了术后恶心呕吐(PONV)的发生率(从28.0%降至9.2%,调整优势比[OR]0.3,95%CI 0.1 - 0.7,P = 0.003),导尿管拔除时间缩短了24小时(从64.0%降至83.0%,调整OR 2.9,95%CI 1.3 - 6.5,P = 0.031),术后第1天(POD 1)的行走能力得到改善(从30.7%提高至75.0%,调整OR 7.5,95%CI 3.6 - 15.8,P<0.0001),经口进食时间缩短(从15小时降至13小时,差值[95%CI],3[1至4],P<0.001),围手术期疼痛管理也得到改善。
择期开颅术后实施加速康复方案比传统围手术期管理具有显著优势。它与术后住院时间、医疗费用和术后并发症的显著降低相关。